Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Assets (2018 - 2021)

Historic Assets for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to $274.1 million.

  • Black Diamond Therapeutics' Assets fell 2087.23% to $274.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $274.1 million, marking a year-over-year decrease of 2087.23%. This contributed to the annual value of $329.7 million for FY2020, which is 10826.31% up from last year.
  • Per Black Diamond Therapeutics' latest filing, its Assets stood at $274.1 million for Q3 2021, which was down 2087.23% from $287.9 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Assets ranged from a high of $362.8 million in Q1 2020 and a low of $51.8 million during Q4 2018
  • Its 4-year average for Assets is $274.9 million, with a median of $313.3 million in 2021.
  • Per our database at Business Quant, Black Diamond Therapeutics' Assets skyrocketed by 20543.55% in 2019 and then tumbled by 2087.23% in 2021.
  • Quarter analysis of 4 years shows Black Diamond Therapeutics' Assets stood at $51.8 million in 2018, then soared by 205.44% to $158.3 million in 2019, then surged by 108.26% to $329.7 million in 2020, then decreased by 16.85% to $274.1 million in 2021.
  • Its Assets was $274.1 million in Q3 2021, compared to $287.9 million in Q2 2021 and $313.3 million in Q1 2021.